Use of Insulin Sensitizers for the Treatment of Major Depressive Disorder: A Pilot Study of Pioglitazone for Major Depression Accompanied by Abdominal Obesity

OBJECTIVE: This study was conducted to examine the safety and efficacy of pioglitazone, a thiazolidinedione insulin sensitizer, in adult outpatients with major depressive disorder. METHOD: In a 12-week, open-label, flexible-dose study, 23 patients with major depressive disorder received pioglitazone...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kemp, David E., Ismail-Beigi, Faramarz, Ganocy, Stephen J., Conroy, Carla, Gao, Keming, Obral, Sarah, Fein, Elizabeth, Findling, Robert L., Calabrese, Joseph R.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2011
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3225727/
https://ncbi.nlm.nih.gov/pubmed/21782251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jad.2011.06.033
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge